Position
Chief Scientific Officer
Company
Outrun Therapeutics
DundeeBiotechnologyHealth CareTherapeuticsDescription
Outrun Therapeutics announces the appointment of Matthew Fyfe as its Chief Scientific Officer. Matthew Fyfe brings over 25 years' experience in drug discovery and development across multiple target classes covering oncology, immunology, neurology, ophthalmology, and metabolic disease. At Outrun, he will be responsible for the advancement of the Company's therapeutics portfolio derived from its novel, proprietary X-E3L (Crosslinking E3 Labeller) technology platform which accelerates the discovery of first-in-class small molecule protein stabilising drugs targeting E3 ligases.
Quick answer
Outrun Therapeutics Appoints Matthew Fyfe as Chief Scientific Officer (January 13, 2025). Outrun Therapeutics is based in Dundee, Scotland, United Kingdom.
- Who is the new Chief Scientific Officer at Outrun Therapeutics?
- Outrun Therapeutics named Matthew Fyfe Chief Scientific Officer, announced January 13, 2025.
- What did Outrun Therapeutics announce on January 13, 2025?
- Outrun Therapeutics announces the appointment of Matthew Fyfe as its Chief Scientific Officer. Matthew Fyfe brings over 25 years' experience in drug discovery and development across multiple target classes covering oncology, immunology, neurology, ophthalmology, and metabolic disease.
- What does Outrun Therapeutics do?
- Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.
- Where is Outrun Therapeutics based?
- Outrun Therapeutics is based in Dundee, Scotland, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Jeune Aesthetics (January 14, 2025), Alpha Cognition (January 14, 2025), Verastem Oncology (January 15, 2025) and Yaqrit (January 10, 2025) also announced leadership changes within 45 days of Outrun Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Jeune Aesthetics, Inc. Appoints Nishant Saxena as Chief Financial Officer (CFO) (January 14, 2025)
- Alpha Cognition Appoints Jen Pesa as Vice President of Commercial and Jack Kelly as Head of Market Access (January 14, 2025)
- Verastem Oncology Appoints Matthew E. Ros as Chief Operating Officer (January 15, 2025)
- Troels Jordansen Appointed as Chief Executive Officer of Yaqrit, replacing Professor Rajiv Jalan (January 10, 2025)
- Pulse Biosciences Appoints Paul A. LaViolette as Chief Executive Officer (January 10, 2025)
- Actimed Therapeutics Appoints Dr. Fabio Dorigotti as Chief Medical Officer following Retirement of Frank Misselwitz (January 16, 2025)
Who to call at Outrun Therapeutics, and when
A new leader at Outrun Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Outrun Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Outrun Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Outrun Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Outrun Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Outrun Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.